Pharmaceutical composition with bisphosphonate

Details for Australian Patent Application No. 2009232033 (hide)

Owner Novartis AG

Inventors Petersen, Holger; Lustenberger, Philipp; Beltz, Karen

Agent Davies Collison Cave

Pub. Number AU-A-2009232033

PCT Pub. Number WO2009/121935

Priority 08154114.6 04.04.08 EP

Filing date 2 April 2009

Wipo publication date 8 October 2009

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 31/663 (2006.01)

A61P 19/00 (2006.01) Drugs for skeletal disorders

C07F 9/6506 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

28 October 2010 PCT application entered the National Phase

  PCT publication WO2009/121935 Priority application(s): WO2009/121935

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009232034-Bicycle suspension system

2009232027-Use of a combination of udenafil and alfuzosin or oxybutynin for the treatment of overactive bladder.